Introduction
Sickle cell disease (SCD) is a multisystem disease resulted from a monogenic mutation of the beta globin from hemoglobin that originates hemoglobin S (HbS) [1] . The term sickle cell disease encompass an amendments set which hemoglobin S is present, including sickle cell anemia (SCA; HbSS) and the others heterozygosis (HbSC, HbSD, S beta thalassemia, among others) [1] . SCD, the heritage disease with bigger prevalence in the world, is originally from Africa and can be found in a variety of countries [1] .
Malnutrition between children and adolescents with SCD is described as common historically, making important to evaluate the growth and development in order to identify the growth speed decrease and the delay influential factors early once the low weight and short stature result in psychosocial [2] impacts exacerbating the clinical scenario.
Malnutrition in children and adolescents may be due to innumerable factors, such as the low consumption of food during the pain crisis or increased metabolism due to increased red blood cells turnover due to hyper hemolysis or the severity of the disease. Therefore, our initial hypothesis was that there would be a high prevalence of malnutrition in this group.
The objective of this review is to describe the nutritional status amendments prevalence and to identify
The accomplished studies in animals and bone-joint diseases patients and the ones that did not included sickle cell disease (HbSS) patients between the evaluated participants were excluded.
Article selection
Two researchers independently made the search. Initially the first researcher made the articles search and the abstract and key words analysis rejecting all not whose fulfilled the inclusion criteria. The second researcher did the full articles reading. We identified and eliminated duplicated articles resulting of different search methods and diversity of descriptors. The two researchers reached a consensus about the eligible articles the according to the following items: sampling procedure clarity, criteria specification of inclusion and exclusion, and properly display of the results.
We identified 46 articles for full reading. Posteriorly, we excluded 9 articles that did not match with the criteria eligibility, therefore, we included 37 articles to the review ( Table 1) .
Data collection process
From the eligible studies were extracted the age associated factors to the growth deficit of children and adolescents with sickle cell disease.
Methods
A literature search using the Medline/PUBMED, SCO-PUS, SciELO and LILACS electronic databases for studies published up to month year was conducted. The search terms sickle cell combined with nutrition, anthropometry, growth retardation, height and weight, Body mass index (BMI) and specific micronutrients (vitamin D and calcium, zinc, iron, and folic acid) were used. From a total of 1402 published studies, 37 with relevant data (21 cross-sectional and 16 longitudinal) were selected.
Election criteria
The articles were eligible when fulfilling the following criteria: 1) Having participants from 0 to 19 years old; 2) Have been published in Portuguese or English or Spanish; 3) Have informed reference standards to growth evaluation; 4) Have described some factors related to the growth (bone mineral density, body composition, linear growth, growth speed, calcium, zinc and vitamin D ingestion and/or serum levels, and/or different treatments effect during growth). Jamaica [3] 298 HbSS children and 157 HbSC children 3 months to 9 years/ longitudinal and descriptive study.
Evaluating the growth and skeletal maturation of prepubertal children with SCD.
Weight and height
A Jamaican cohort study of sickle cell disease.
Weight and height deficit associated with delayed growth. Singhal, et al. 1994 Jamaica [26] 132 We observed weight loss (< 80%) by Waterlow classification in 41% of boys and 25% of girls with SCD and height deficit (< 90%) in 25% of boys and 25% of girls with SCD. Soliman, et al. 1995 Oman [22] 90 prepubertal children ( Tanner 1) (25 with GHD,  15 HbSS and GHD, 30 with normal variants of short stature and 20 with normal stature)/4 to 10 years/cross-sectional and case-control study.
Comparing growth, pituitary function and CT evaluation of the hypothalamicpituitary area in children with GHD, children with SCD and GHD, children of the same age with short stature and normal children of the same age.
BMI Tanner classifications, 1976
All children with sickle cell anemia and empty saddle had BMI below the 5th percentile for age. Soliman, et al. 1997 Oman [21] 21 HbSS prepubertal children with SCA and short stature/age of children and GHD: 6.6 years; SCA and normal response to GH: 7.3 years; GHD isolated: 7.3 years/cross-sectional and descriptive study.
Testing the hypothesis that SCA is associated with abnormalities of the IGF-1, IGFB-3 and GH resistance axes.
Height/age and Weight/age French sickle cell disease group.
Basal concentrations of IGF-1 and IGFBP-3 were significantly lower in the group with SCA and deficient GH secretion. Children with SCA have lower significant IGF-1 production in response to GH, suggesting partial resistance to GH. BMI did not show any difference between the groups, but 9 of the 21 showed slower linear growth speed and lower concentrations of IGF-I and IGFBP-3. de Montalembert, et al. 1997 France [36] 35 children and adolescents with SCD/3 to 20 years (average of 11 years)/longitudinal and descriptive study.
Observing the safety and efficiency of HU in children with severe SCD.
Weight/height NCHS, 1977
The HU had good tolerance in short and medium term. No difference in growth speed in any of the three groups of children and adolescents. Z-scores were similar at the beginning of the study, after 1 year and after 2 years of treatment, excluding the adverse effect of HU on growth in this cohort. Leonard, et al. 1998 USA [14] 104 HbSS children and adolescents/4 to 18 years/cross-sectional and descriptive study.
Determining the relation of plasma zinc to growth and maturation of children with SCA.
Weight and height HUG-KIDS study 44% of the children had low plasma Zn. They had a significant decrease in weight (-1.00 ± 0.15 ZS vs. -0.14 ± 0.13 ZS, p = 0.003) and height (-0.78 ± 0.15 ZS vs. -0.15 ± 0.14 ZS, p = 0.003) compared to those with normal Zn. Kinney, et al. 1999 USA [41] 84 HbSS children/9.8 ± 3.2 years (average of 9.1 years)/longitudinal and descriptive study. 100% of children gained weight, height, fat and fat free mass. HU increased the Hb from 8.0 g/dL at the beginning to 8.4 g/dL at the end of the study, which may improve growth as well as reduce hypermetabolism.
Luporini, et al. 2001
Brazil [23] 41 children with SCA/2.8 to 15.0 years (average of 8.5)/cross-sectional and descriptive study.
Analyzing the relation between growth in children with SCA and the different betaglobin haplotypes, as well as components of IGF-1 and IGFBP-3.
Weight/age and Height/age NCHS, 1977
Plasma concentrations of IGF-1 and IGFBP-3 were low in all patients with SCA. The positive relation between hematocrit and Hb F with total IGF-1, free/total IGF-1 and IGFBP-3 in patients with SCA showed that the growth delay of these patients may relates to intrinsic factors of the disease.
Patients with the CAR/CAR haplotype had significantly slower growth speed compared to those with BEN/BEN. Silva, et al. 2002 Brazil [18] 100 children (73 with Hb SS and 27 with Hb SC) under 8 years old/longitudinal and descriptive study. Jamaica [37] 72 children ( Initial and final weight and height.
HCT Multicenter Study for sickle cell anemia 33% had low BMD in the proximal femur and 56% in the lumbar spine. 60% low serum calcium (< 1,300 mg) and low vitamin D level (< 7.5 nM in 30%, < 50 nM in 74% and ≤ 62.5 nM in 100% of those evaluated). Eggleston, et al. 2007 USA [40] 53 HbSS children and adolescents/< 16 years/ Multicentric, longitudinal and descriptive study. Reduced BMC corrected for age in the last year of follow-up.
Weight-for-age Z-score Males: -1.2 ± 1.1 (-3.2 to 1.1) Females: -0.5 ± 0.9 (-2.1 to 1.5) Height-for-age Z-score Males: -0.9 ± 1.1 (-3.2 to 1.7)
Females: -0.1 ± 1.0 (-2.7 to 1.8) Rhodes, et al. 2009 USA [9] 33 HbSS children/10 to 13 years/longitudinal and descriptive study. Smallest range of weight and W/H in SCA patients than in the controls, however, there was no significant difference in height (p = 0.06) and in BMI/A (p = 0.12) among the SCA patients and controls (p < 0.01). The mean values of body weight, height and BMI of the SCA subjects were consistently lower than those of the NCHS standards, and the difference increased with advancing age, affecting more males. Dougherty, et al. 2011 USA [31] 151 children (35 HbSS and 103 controls)/5 to 3 years (controls average: 8.6 ± 1.8 and HbSS: 9.0 ± 2.2)/crosssectional and descriptive study.
Analyzing the maximum muscle strength and peak power in children with SCA. 
Prevalence of nutritional status changes
The height and weight deficit values vary from 8.2% to 34.9% and from 3.7% to 100% respectively, and overweight vary from 1.6% to 22.4%. The emergence of weight and height compromise seems to be early, as we see in Stevens, et al. [3] , which observed weight and height deficit before the age of 2 years on children with SCA. However, we observed overweight/obesity presgroup of the individuals, the nutritional status parameters, the prevalence of nutritional parameter classifications and the described factors that interfered in the nutritional status.
Results

Study characteristics
Predominantly the studies type was descriptive (n = 34) with great variation in the sample number (from 8 to 675 participants) and in age (between 0 to 19 years old) ( Table 1) .
Study results
The studies applied varied the growth evaluation parameters. In addition, we observed the use of weight in 15 studies; of stature in 18 studies and of anthropometrics indicators in most studies (Height/age (H/A) in 17 Nogueira, et al. 2015 Brazil [6] 357 HbSS and HbSC children/2 to 6 years (average: 3.7 years)/crosssectional and descriptive study.
Describing the history of maternal breastfeeding and the anthropometry of children with SCD, with early diagnosis and obtained by neonatal screening, followed up at a referral service in neonatal screening of a state with a high incidence of hemoglobinopathies.
Weight/age, Height/age and Weight/height For eutrophic children, mean MBF time was almost four times higher than for malnourished children (p < 0.01) and 5% of children presented height deficit. History of hand-foot syndrome and more than 3 transfusions per patient were associated with an increased age were associated with an increased risk of malnutrition. of short stature was related to a history of hand-foot syndrome and to the need for more than three transfusions per patient, in addition, malnutrition with vessel occlusion crises higher to two per year and the need for the first blood transfusion before 12 months old.
Evaluation of growth used different reference standards, with the NCHS growth curve being the most used, since they were twenty-one studies prior to the publication of the 2006 and 2007 WHO growth curve. However, regardless of the standard used, the weight and height deficits were prevalent in children and adolescents with SCD [3] [4] [5] [6] [7] 13, 14, 17, 18, 20, 25, [27] [28] [29] [30] [31] [32] [33] .
In contrast, the predominance of normal and the presence of overweight or obesity observed in the more recent studies [4, 6, 7, 17, 19] changes the nutritional profile of this group. These findings are important and possibly results of improved health care for people with sickle cell disease and changes in diet for the world's population.
The existence of extremes, namely of growth deficit or overweight/obesity, reinforces the need to monitor nutritional status, once both may aggravate the pathological conditions of children and adolescents with SCD, favoring a higher contraction of infections [2, 34] and respiratory complications [2, 34] .
Some factors affected nutritional status, such as clinical variables (hemoglobin concentration), disease progression (cardiac output and erythropoiesis increase, favoring REE increase), nutritional factors (low food intake and micronutrient depletion) and the type of treatment implemented.
In Bennett's study [35] four factors identified contributed to the delayed growth of children with SCA: Endocrine dysfunction, hypermetabolism, inadequate food intake, and micronutrient deficiencies, which reinforces the results found in this review.
The increase in REE [8, 36] directly contributes to the increase in energy needs, since it corresponds to 65% to 70% of the total daily energy expenditure [37] . Therefore, it can lead to the growth deficit only or when associated with a decrease in food consumption, common in hospitalized children for allergic crisis [8] . Individual nutritional monitoring of the child should be implemented in order to minimize hyperoxia, increase daily energy consumption and, consequently, restore nutritional status.
Furthermore, lack attention in the monitoring of essential micronutrients for child growth, which are commonly low in consumption, such as calcium [11, 12] and vitamin D [12, 16] or that were in low serum concentration, such as zinc [14, 15] and vitamin D [11, 12, 16] increases the risk of malnutrition. Therefore, they need to be monitored during the nutritional follow-up. Micronutrient depletion contributes to the onset of low bone mineral density [11, 12] , of delays in skeletal maturation and growth deficit [15] . The importance of this monitorence mostly as of 2011's published studies [4] [5] [6] [7] .
Associated factors with nutritional status
The associated factors with growth deficit were resting energy expenditure (REE) [8] increase; Low mineral bone density [9] [10] [11] [12] [13] ; Plasma concentration of micronutrients decrease [11, [13] [14] [15] [16] [17] ; Low concentration of hemoglobin [4, 5, 9, [18] [19] [20] ; The low food intake; Hormonal alterations [13, [21] [22] [23] [24] , Vessel occlusion crises and increased need of transfusion [25] .
However, the associated factor with overweight was the biggest Hb concentration, indicating the best disease prognosis, according to Chawla, et al. study [4] . Bone mineral density (BMD) was assessed in five studies. Dietary intake of micronutrients in 4 studies (vitamins B12 and A in 1 study, vitamin C in 1 study, vitamin D and calcium (Ca) in 3 studies, zinc (Zn), iron (Fe) and folic acid in 1 study). Zn plasma concentration in 2 studies. Serum levels of Ca in 2 studies and vitamin D in 3 studies.
The presence of low BMD varied between 14% and 56%; Low calcium and vitamin D intake varied between 48% and 75%; Low serum zinc concentration between 15 and 44% moreover vitamin D between 66% and 100%.
Discussion
This review found the following results: a) The magnitude of short stature ranged from 8.2% to 24% and low weight from 3.7% to 100%; b) The presence of overweight or obesity is already detected between 1.6% and 22.4%; c) The factors associated with the growth deficit described in the articles were: Increased resting energy expenditure around 17% and nutritional deficiencies (low calcium and vitamin D intake between 48% and 75%; Low serum zinc concentration between 15 and 44%, vitamin D between 66% and 100%); d) Other factors described (presence of low bone mineral density between 14% and 56%, low Hb concentration, transfusions frequency and onset, complications frequency such as vessel occlusion and hand-foot syndrome, and the presence of hormonal alterations.
Abstract of evidences
The weight and length at birth of the child with SCD are usually normal and change until the end of the first year of life, culminating with low weight and short stature in childhood [2] . However, the child can reach normal height in adolescence, because the growth spurt occurs late due to delay in the closure of the epiphyses, which allows the recovery of stature in the adult phase [2, 26] . As for short stature, it usually was associated with low bone mineral density [10] [11] [12] and the deficiency of some micronutrients such as zinc [15, 16] , calcium [12] and vitamin D [11, 12] .
The Kazadi study [25] noted that the increased risk
The different treatments evaluated presented benefits or minimized the growth deficit; However, more studies are necessary to evaluate the late effects of each type of treatment. Early diagnosis and appropriate treatment can reduce or avoid complications of the disease, so it is extremely important to follow up with professionals from different specialties, as well as the family and the community to know about the disease and its basic care [44] .
The present study evidenced a high prevalence of weight and height deficits in this group, existing, although, the presence of overweight/obesity in those with better clinical conditions. The main factors associated with the growth deficit were described, which may lead to a more adequate clinical practice, since it makes it possible to prevent the occurrence of both growth and obesity deficits. Therefore, evidence-based interventions designated to prevent and minimize these changes in nutritional status.
Limitations
The studies analyzed have several methodological limitations. First, most studies have a wide breadth of age, mixing infants, preschoolers, schoolchildren, adolescents, and young adults. Secondly, they did not investigate the action of different physio pathological and therapeutic aspects in the same group of children and adolescents. Third, there was a variability of several growth reference standards, which did not allow the comparison of the data. Finally, there was a predominance of descriptive cross-sectional studies, which did not allow to conjecture a possible time line between the associated factors and the compromising of nutritional status.
ing was evident in the randomized clinical study which, when supplementing children with SCA with 10 mg of elemental Zn for 12 months, showed significant stature gain [15] .
Adequate clinical follow-up of the person with SCD usually results improvement in hemoglobin concentration. Adequate levels of hemoglobin in these patients, as evidence shows, avoid important complications such as aplastic crisis, splenic sequestration crisis, stroke, among others [27] . In addition, it was also observed that children with lower P/I were those with lower Hb concentration [19] ; And those with higher Hb concentrations [5] were associated with overweight and obesity, as well as with the use of hydroxyurea (HU) [8, 38] and continuous blood transfusion [21] . Endocrine compromise is also one of the factors that interferes with these children's growth. Those with SCD and low stature had low basal IGF-1 [21] [22] [23] [24] concentrations and/or IGF-binding protein-3 (IGFBP-3) [21, 23, 24] and/or growth hormone (GH) deficient [21] [22] [23] . The deficiency of these hormones relates to slow growth and short stature in children with SCA, however, the Ca, the micronutrient involved in growth, was normal in evaluated children [21] . Soliman, et al. [22] identified the presence of empty turmeric saddle in all children who had GH deficiency, which is suggestive of ischemic lesion in the pituitary gland. Therefore, in the persistence of nutritional deficits it is necessary to investigate these hormones.
In relation to the studied treatments [8, 19, [38] [39] [40] , these seem to positively impact on growth and development by improving the clinical picture of the disease. However, should be noted that the studies with HU [8, 38, 39, 41 ] had a small sample number, ranging from 8 to 84 patients and short follow-up periods, from 4 months to 2 years. The results with the HU use in the nutritional state ranged from no difference in growth velocity [36] to weight gain, height [8, 39] and fat free mass [41] .
Another treatment, hematopoietic cell transplantation (HCT) seems to not impair growth [40, 42] , but it is not advisable to perform it in the next period or during the growth spurt of adolescence [40, 43] . The association between growth deficiency and HCT may be related partly to gonadal toxicity due to the busulfan (BU) doses administered. The likelihood of growth speed reduction is higher if the inhibitory effect of BU on gonadal function is exercised before the completion of the pubertal growth peak or the institution of hormone replacement therapy [40] . Despite this study [40] did not describe growth improvement with transplantation, it brings important contributions in guiding the most appropriate moment for its realization, in order to avoid losses in growth. Walters, et al. [42] observed improvement in linear growth after transplantation, however, they described the adverse effect of BU on the ovarian function of five of seven girls evaluated with age above 13 years old.
